ScienceDirect® Home Skip Main Navigation Links
You have guest access to ScienceDirect. Find out more.
 
Home
Browse
My Settings
Alerts
Help
 Quick Search
 Search tips (Opens new window)
    Clear all fields    
advertisementadvertisement
Current Opinion in Biotechnology
Volume 9, Issue 2, April 1998, Pages 157-163
 
Font Size: Decrease Font Size  Increase Font Size
 Abstract - selected
Purchase PDF (615 K)

 
 
 
Related Articles in ScienceDirect
View More Related Articles
 
Special issue
View Record in Scopus
 
doi:10.1016/S0958-1669(98)80109-2    How to Cite or Link Using DOI (Opens New Window)
Copyright © 1998 Published by Elsevier Science Ltd. All rights reserved.

Refolding of recombinant proteins

Eliana De Bernardez ClarkE-mail The Corresponding Author

Department of Chemical Engineering, Tufts University, Medford, MA 02155, USA

Available online 11 February 2002.

Purchase the full-text article



References and further reading may be available for this article. To view references and further reading you must purchase this article.

Abstract

Expression of recombinant proteins as inclusion bodies in bacteria is one of the most efficient ways to produce cloned proteins, as long as the inclusion body protein can be successfully refolded. Aggregation is the leading cause of decreased refolding yields. Developments during the past year have advanced our understanding of the mechanism of aggregation in in vitro protein folding. New additives to prevent aggregation have been added to a growing list. A wealth of literature on the role of chaperones and foldases in in vivo protein folding has triggered the development of new additives and processes that mimic chaperone activity vitro.

Abbreviations: DTT dithiotreitol; GdmCl guanidinium chloride

Article Outline

• References

 
Home
Browse
My Settings
Alerts
Help
Elsevier.com (Opens new window)
About ScienceDirect  |  Contact Us  |  Information for Advertisers  |  Terms & Conditions  |  Privacy Policy
Copyright © 2008 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.